TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BYNFEZIA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

BYNFEZIA

ST13

US500000088620337

Class

5

Filing

88620337

Registration

6116740

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

07/09/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

09/17/2019

Registration date

08/04/2020

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/04/2020

Last transaction

07/09/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

16

Owner location

Mumbai, Maharashtra, IN

Examiner

FATHY, DOMINIC

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Sun Pharmaceutical Industries Limited

Representatives

Craig Kuchii, Esq. SUN PHARMACEUTICAL INDUSTRIES, INC.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and medicinal preparation for the management of gastrointestinal endocrine tumors; Pharmaceutical and medicinal preparation for the management of acromegaly, carcinoid tumors, and vasoactive intestinal peptide tumors

Publications

History of USPTO decisions and trademark events.

19 publications found

ES8R

TEAS SECTION 8 RECEIVED

07/07/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/04/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/19/2020

PUBO

PUBLISHED FOR OPPOSITION

05/19/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/29/2020

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

04/14/2020

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

04/10/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/03/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/03/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/03/2020

ALIE

ASSIGNED TO LIE

04/03/2020

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

03/26/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

12/19/2019

GNSL

LETTER OF SUSPENSION E-MAILED

12/19/2019

CNSL

SUSPENSION LETTER WRITTEN

12/19/2019

DOCK

ASSIGNED TO EXAMINER

12/17/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/24/2019

NWAP

NEW APPLICATION ENTERED

09/20/2019

Continuous trademark protection

Get notified about every new filing that threatens BYNFEZIA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.